# Geri-Care Pharmaceuticals Corp. – FDA Inspection, May 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/geri-care-pharmaceuticals-corp/8314eac1-097e-4bec-b989-98e946fdc2db
Source feed: FDA_Inspections

> FDA inspection 1269791 of Geri-Care Pharmaceuticals Corp., May 05, 2025. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269791
- Company Name: Geri-Care Pharmaceuticals Corp.
- Inspection Date: 2025-05-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 5

## Related Documents

- FDA Inspection 1085751 - 2019-03-08
- FDA Inspection 1027069 - 2017-09-14
- [FDA Inspection 886331 - 2014-06-12](https://www.keypedia.com/records/fda_inspections/geri-care-pharmaceuticals-corp/702d59f8-5bce-4978-969c-9b20276ace1a)
- FDA Inspection 793414 - 2012-08-02
- FDA Inspection 705311 - 2011-01-13

## Related Officers

- [Investigator](https://www.keypedia.com/people/alisha-b-patel/3c106dac-0e0d-41f2-9f7a-69982d4e6579)
- [FDA Associated Person](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)

Company: https://www.keypedia.com/companies/geri-care-pharmaceuticals-corp/d8db3389-a5a8-420c-98d3-18233610e854

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
